Targeting circular RNAs as a therapeutic approach: current strategies and challenges

Alina T He1, Jinglei Liu2, Feiya Li1,3

  • 1Sunnybrook Research Institute, Toronto, ON, Canada.

Insights

Circular RNAs (circRNAs) are key in cellular processes and disease. New methods using nanoparticles, exosomes, and CRISPR/Cas13 offer therapeutic potential for manipulating circRNA levels.

Area of Science:

  • Molecular Biology
  • Genetics
  • Biotechnology

Background:

  • Circular RNAs (circRNAs) are increasingly recognized for their roles in cellular functions.
  • Dysregulation of circRNAs is linked to various disease pathologies.
  • Their stability and specificity make circRNAs promising therapeutic targets.

Purpose of the Study:

  • To review the properties and functions of circRNAs.
  • To highlight the significance of circRNAs in disease pathogenesis.
  • To summarize current and emerging strategies for circRNA manipulation in therapeutics.

Main Methods:

  • Discussion of gain-of-function (expression plasmids) and loss-of-function (RNA interference) strategies.
  • Exploration of nanoparticle and exosome delivery systems to enhance therapeutic delivery.
  • Overview of advanced knockdown techniques including cre-lox and CRISPR/Cas13 systems.

Main Results:

  • CircRNAs exhibit unique stability and tissue-specific expression patterns.
  • Various methods exist for modulating circRNA expression, each with advantages and limitations.
  • Novel delivery systems and gene-editing tools show promise for precise circRNA targeting.

Conclusions:

  • CircRNAs hold significant therapeutic potential due to their disease relevance and unique characteristics.
  • Advancements in delivery systems and gene-editing technologies are crucial for developing effective circRNA-based therapies.
  • Further research is needed to overcome challenges and realize the full therapeutic promise of circRNAs.

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.4K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.9K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
595